Rita Rubin, Drugmakers to voluntarily post info online about clinical trials, USA Today, January 7, 2005. Excerpt: 'The prescription drug industry's main trade group announced Thursday that its member companies will begin voluntarily posting information about ongoing clinical trials for all diseases this summer on a government Web site. Drug companies have come under fire in recent months for allegedly withholding unfavorable research findings, and the American Medical Association as well as some members of Congress have called for mandatory reporting of all clinical-trial results. Under current law, drug companies are required to post information at www.clinicaltrials.gov only about trials of drugs for serious or life-threatening diseases or conditions. "We're doing this because our industry recognizes that sometimes what the law requires doesn't give patients all they need," Billy Tauzin, the former congressman who now serves as CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA), said in a statement Thursday. At least two congressmen on Thursday said PhRMA's voluntary plan, which is to go into effect July 1, is inadequate.' (Thanks to ResourceShelf.)
Posted by
Peter Suber at 1/10/2005 08:48:00 AM.
The open access movement:
Putting peer-reviewed scientific and scholarly literature
on the internet. Making it available free of charge and
free of most copyright and licensing restrictions.
Removing the barriers to serious research.
I recommend the OA tracking project (OATP) as the best way to stay on top of new OA developments. You can read the OATP feed on a blog-like web page or subscribe to it by RSS, email, or Twitter. You can also help build the feed by tagging new developments you encounter.
